Search Results - "Poterucha, John"

Refine Results
  1. 1

    Drug-Induced Liver Injury by Leise, Michael D., MD, Poterucha, John J., MD, Talwalkar, Jayant A., MD

    Published in Mayo Clinic proceedings (2014)
    “…Abstract Drug hepatoxicity can be nonidiosyncratic (predictable), as in the case of acetaminophen, or idiosyncratic (unpredictable). This review article…”
    Get full text
    Journal Article
  2. 2

    Incidence and Risk Factors for Adverse Events Related to Image-Guided Liver Biopsy by Boyum, James H., MD, Atwell, Thomas D., MD, Schmit, Grant D., MD, Poterucha, John J., MD, Schleck, Cathy D., BS, Harmsen, W. Scott, MS, Kamath, Patrick S., MD

    Published in Mayo Clinic proceedings (01-03-2016)
    “…Abstract Objective To determine the incidence of major adverse events related to a large volume of image-guided liver biopsies performed at our institution…”
    Get full text
    Journal Article
  3. 3

    Management of Hepatic Encephalopathy in the Hospital by Leise, Michael D., MD, Poterucha, John J., MD, Kamath, Patrick S., MD, Kim, W. Ray, MD

    Published in Mayo Clinic proceedings (01-02-2014)
    “…Abstract Hepatic encephalopathy (HE) develops in up to 50% of patients with cirrhosis and is a feature of decompensated cirrhosis. With the goal of reviewing…”
    Get full text
    Journal Article
  4. 4

    Long‐term outcomes of patients undergoing simultaneous liver transplantation and sleeve gastrectomy by Zamora‐Valdes, Daniel, Watt, Kymberly D., Kellogg, Todd A., Poterucha, John J., Di Cecco, Sara R., Francisco‐Ziller, Nicki M., Taner, Timucin, Rosen, Charles B., Heimbach, Julie K.

    Published in Hepatology (Baltimore, Md.) (01-08-2018)
    “…Obesity is increasingly common before and after liver transplantation (LT), yet optimal management remains unclear. The aim of this study was to analyze the…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Natural History of Hepatitis B Virus Infection: An Update for Clinicians by Pungpapong, Surakit, MD, Kim, W. Ray, MD, Poterucha, John J., MD

    Published in Mayo Clinic proceedings (01-08-2007)
    “…Hepatitis B virus (HBV) is a common viral pathogen that causes a substantial health burden worldwide. Significant progress has been made in the past few…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Liver Involvement in Systemic Lupus Erythematosus: Case Review of 40 Patients by CHOWDHARY, Vaidehi R, CROWSON, Cynthia S, POTERUCHA, John J, MODER, Kevin G

    Published in Journal of rheumatology (01-11-2008)
    “…Objective Subclinical liver involvement is frequent in systemic lupus erythematosus (SLE). We sought to determine the presence of endstage liver disease in…”
    Get full text
    Journal Article
  10. 10

    Evaluation of Elevated Liver Enzymes by Lee, Tae Hoon, MD, Kim, W. Ray, MD, Poterucha, John J., MD

    Published in Clinics in liver disease (01-05-2012)
    “…Liver enzymes, including aminotransferases and alkaline phosphatase, are some of the most commonly ordered blood tests in a physician's practice. These enzymes…”
    Get full text
    Journal Article
  11. 11

    Evaluation of abnormal liver biochemical test results: Does the hare finally beat the tortoise? by Poterucha, John J, Friedman, Lawrence S

    Published in Journal of hepatology (01-02-2017)
    “…Poterucha et al discuss the study conducted by Tapper and colleagues presenting a refreshing scientific effort to identify a preferred approach to identifying…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Longterm clinical and radiological follow‐up of living liver donors by Murad, Sarwa Darwish, Fidler, Jeff L., Poterucha, John J., Sanchez, William, Jowsey, Sheila G., Nagorney, David, Rosen, Charles B., Heimbach, Julie K.

    Published in Liver transplantation (01-07-2016)
    “…Although short‐term risks of living donor hepatectomy have been well defined, little is known about the longterm impact. We aimed to perform a systematic…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Surveillance for liver complications after the Fontan procedure by Hilscher, Moira B, Johnson, Jonathan N, Cetta, Frank, Driscoll, David J, Poterucha, John J, Sanchez, William, Connolly, Heidi M, Kamath, Patrick S

    Published in Congenital heart disease (01-03-2017)
    “…The physiological consequences of the Fontan circulation impose risk for hepatic dysfunction and may culminate in hepatic fibrosis, cirrhosis, and…”
    Get more information
    Journal Article
  17. 17

    Ultrasound‐based transient elastography for the detection of hepatic fibrosis in patients with recurrent hepatitis C virus after liver transplantation: A systematic review and meta‐analysis by Adebajo, Corlan O., Talwalkar, Jayant A., Poterucha, John J., Kim, W. Ray, Charlton, Michael R.

    Published in Liver transplantation (01-03-2012)
    “…Ultrasound‐based transient elastography (TE) is a promising noninvasive alternative to liver biopsy for the detection of hepatic fibrosis due to recurrent…”
    Get full text
    Journal Article
  18. 18

    IgG4+ Plasma Cell Infiltrates in Liver Explants With Primary Sclerosing Cholangitis by LIZHI ZHANG, LEWIS, Jason T, WU, Tsung-Teh, ABRAHAM, Susan C, SMYRK, Thomas C, LEUNG, Stanley, CHARI, Suresh T, POTERUCHA, John J, ROSEN, Charles B, LOHSE, Christine M, KATZMANN, Jerry A

    “…Sclerosing cholangitis can be primary (PSC) or secondary. One unusual cause of secondary sclerosing cholangitis is the newly recognized entity of…”
    Get full text
    Journal Article
  19. 19

    Outcome of liver transplantation for hepatitis B in the United States by Kim, W. Ray, Poterucha, John J., Kremers, Walter K., Ishitani, Michael B., Dickson, E. Rolland

    Published in Liver transplantation (01-08-2004)
    “…Important innovations, such as hepatitis B immune globulin (HBIG) and lamivudine, have been introduced to the care of patients undergoing liver transplantation…”
    Get full text
    Journal Article
  20. 20